XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Research

XyloCor Therapeutics

Albert Gianchetti

Todd Rosengart

Dawn Byrnes

Tracy Rarick

A. Brian Davis

Rémi Gloeckler

Howard Dittrich

Alexander Gaidamaka

The board of directors at XyloCor Therapeutics has a history of experience in the venture capital, pharmaceutical, and engineering industries. Members of the board have also been educated at esteemed universities such as Lehigh and McGill.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at XyloCor Therapeutics

Leadership Team

CEO and Executive Team